CATHEDRA BITCOIN INC
CBTTF
DMG BLOCKCHAIN SOLUTIONS INC
DMGGF
Ebang International
EBON
Bitdeer Technologies
BTDR
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin, Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.